Long COVID significantly affects children for up to 36 months, vaccines offer crucial protection

Study reveals the significant and lasting impact of long COVID on children, emphasizing the protective role of vaccines and the increased risk of autoimmune disorders.

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum’s IPO in South Korea

Plus, news about Caliway Pharmaceuticals, argenx, Halozyme Therapeutics, Verrica, Liquidia and Pharmosa: FDA lifts partial clinical hold on Avidity Biosciences’ drug: Sign up to read

October 4, 2024

Sage suffers pipeline setback with failure of drug to treat essential tremor

Sage Therapeutics said Wednesday that an experimental pill failed to quell involuntary muscle shaking in patients with a neurological condition called essential tremor. The negative

July 24, 2024

Lilly budgets additional $5.3B for tirzepatide API factory in Indiana

Eli Lilly is further boosting manufacturing in its home state of Indiana. The company said it is allocating an additional $5.3 billion into its budget

May 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.